Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052688 · ClinicalTrials.gov registry record
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 150
- Enrollment target
NCT01052688: Completed study, sponsored by Sequenom.
NCT01052688 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01052688 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
To collect samples for the purpose of developing and optimizing an in vitro noninvasive prenatal diagnostic (NIPD) test. The NIPD test employs circulating cell free (ccff) DNA extracted from whole blood samples collected from women who are pregnant with a fetus previously determined to have a chromosomal abnormality. The NIPD result will be compared to the standard test results obtained from other test methods such as karyotype, FISH, QF-PCR, and/or any commercially available NIPD test.
Primary Outcome
Result of NIPD test will be compared to the standard test results obtained by karyotype, FISH, QF-PCR, and/or commerical NIPD result.
Interventions
- OTHER Maternal blood draw of 30 to 50ml
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-11 |
| Est. Completion | 2021-08-31 |
What the finished NCT01052688 record still lists
NCT01052688 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Maternal blood draw of 30 to 50ml is the first listed.
NCT01052688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01052688 about?
NCT01052688 is a clinical study titled "Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies". To collect samples for the purpose of developing and optimizing an in vitro noninvasive prenatal diagnostic (NIPD) test. The NIPD test employs circulating cell free (ccff) DNA extracted from whole blood samples collected from women who are pregnant with a fetus previously determined to have a chromo...
What is the current status of trial NCT01052688?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2009-11. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT01052688?
The interventions under investigation include: Maternal blood draw of 30 to 50ml (OTHER).
Who is sponsoring clinical trial NCT01052688?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia